Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 932.50 -16.35 (-1.72%) | NSE 933.60 -15.65 (-1.65%) | Trade | Add

BSE Live

Dec 05, 16:01

932.50 -16.35 (-1.72%)

Volume

AVERAGE VOLUME

5-Day

262,963

10-Day

356,619

30-Day

159,976

43,801

Prev. Close

948.85
Open Price

947.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 05, 15:59

933.60 -15.65 (-1.65%)

Volume

AVERAGE VOLUME

5-Day

4,065,593

10-Day

4,744,636

30-Day

2,179,446

838,020

Prev. Close

949.25
Open Price

945.00

Bid Price (Qty.)
933.60 (3)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Natco Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,076.60	3,548.90	2,340.80	1,761.70	1,617.70
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	4,076.60	3,548.90	2,340.80	1,761.70	1,617.70
Total Operating Revenues	4,094.50	3,568.90	2,351.00	1,767.80	1,653.50
Other Income	321.30	104.70	85.50	94.60	101.10
Total Revenue	4,415.80	3,673.60	2,436.50	1,862.40	1,754.60
EXPENSES
Cost Of Materials Consumed	536.20	522.50	475.30	519.20	372.90
Purchase Of Stock-In Trade	45.50	34.80	19.80	20.90	174.00
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	11.60	17.20	34.60	-5.50	-46.90
Employee Benefit Expenses	515.30	454.90	425.70	410.10	380.00
Finance Costs	19.60	14.50	8.60	13.30	11.30
Depreciation And Amortisation Expenses	220.00	171.90	150.90	138.40	115.20
Other Expenses	841.60	902.50	550.90	610.10	355.90
Total Expenses	2,189.80	2,118.30	1,665.80	1,706.50	1,362.40
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,226.00	1,555.30	770.70	155.90	392.20
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	2,226.00	1,555.30	770.70	155.90	392.20
Tax Expenses-Continued Operations
Current Tax	407.50	284.80	133.10	32.50	93.30
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-31.90	-36.10	0.50	-15.70	-10.60
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	375.60	248.70	133.60	16.80	82.70
Profit/Loss After Tax And Before ExtraOrdinary Items	1,850.40	1,306.60	637.10	139.10	309.50
Profit/Loss From Continuing Operations	1,850.40	1,306.60	637.10	139.10	309.50
Profit/Loss For The Period	1,850.40	1,306.60	637.10	139.10	309.50
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	103.31	72.79	34.90	7.63	16.99
Diluted EPS (Rs.)	103.31	72.79	34.90	7.63	16.96
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	107.50	170.20	100.40	82.10	113.90
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	300.00	475.00	275.00	225.00	263.00